LYNDRA Trademark

Trademark Overview

On Thursday, August 12, 2021, a trademark application was filed for LYNDRA with the United States Patent and Trademark Office. The USPTO has given the LYNDRA trademark a serial number of 90879064. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, June 25, 2024. This trademark is owned by Lyndra Therapeutics, Inc.. The LYNDRA trademark is filed in the Pharmaceutical Products category with the following description:

House mark for a full line of pharmaceutical products, preparations, and substances
lyndra

General Information

Serial Number90879064
Word MarkLYNDRA
Filing DateThursday, August 12, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, June 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 21, 2022

Trademark Statements

Goods and ServicesHouse mark for a full line of pharmaceutical products, preparations, and substances

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 4, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLyndra Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472
Party NameLyndra Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472

Trademark Events

Event DateEvent Description
Monday, October 4, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 18, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 16, 2021NEW APPLICATION ENTERED
Thursday, May 12, 2022ASSIGNED TO EXAMINER
Tuesday, June 21, 2022PUBLISHED FOR OPPOSITION
Wednesday, June 1, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 21, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 16, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, February 16, 2023SOU TEAS EXTENSION RECEIVED
Thursday, February 16, 2023SOU EXTENSION 1 FILED
Thursday, February 16, 2023SOU EXTENSION 1 GRANTED
Saturday, February 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 10, 2023SOU TEAS EXTENSION RECEIVED
Monday, July 10, 2023SOU EXTENSION 2 FILED
Monday, July 10, 2023SOU EXTENSION 2 GRANTED
Wednesday, July 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 3, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 3, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 3, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 31, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 31, 2024SOU EXTENSION 3 FILED
Wednesday, January 31, 2024SOU EXTENSION 3 GRANTED
Tuesday, June 25, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, June 25, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 25, 2024SOU EXTENSION 4 GRANTED
Tuesday, June 25, 2024SOU EXTENSION 4 FILED
Friday, February 2, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 3, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Related Keywords

lyndra products preparations substances pharmaceutical line mark full house